IGFBP3 and cancer: It was shown earlier that the linear, polyanionic, sulfated GAG heparin, known to possess anti-cancer properties, competes for IGFBP-3-binding to cell surface HSPGs resulting in increased IGFBP-3 accumulation in the media [49].